Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

TRP14 promotes resistance to cisplatin by inducing autophagy in ovarian cancer

2 Aug 2019

Abstract excerpt

Cisplatin is a common chemotherapeutic agent against ovarian cancer; however, drug resistance is a major limiting factor for its use in clinical treatment. The underlying mechanisms of cisplatin resistance in ovarian cancer have not yet been fully elucidated. Thus, this study aimed to elucidate some of the mechanisms responsible for resistance to cisplatin in ovarian cancer. The results demonstrated that the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Endoplasmic Reticulum Stress and Disease
Share to Sirtuins and Resveratrol in Medicine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31524236
DOI: 10.3892/or.2019.7258

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

TRP14 promotes resistance to cisplatin by inducing autophagy in ovarian cancerPMID 31524236Read ↗

Molecular mechanisms of cisplatin resistance in ovarian cancerSemantic proximity Read ↗

Downregulation of ATG14 by EGR1-MIR152 sensitizes ovarian cancer cells to cisplatin-induced apoptosis by inhibiting cyto-protective autophagySemantic proximity Read ↗

MicroRNAs as the critical regulators of autophagy-mediated cisplatin response in tumor cellsSemantic proximity Read ↗

Autophagy-driven regulation of cisplatin response in human cancers: Exploring molecular and cell death dynamicsSemantic proximity Read ↗

The mTORC2 Component Rictor Contributes to Cisplatin Resistance in Human Ovarian Cancer CellsSemantic proximity Read ↗

SHCBP1 promotes cisplatin resistance of ovarian cancer through AKT/mTOR/Autophagy pathwaySemantic proximity Read ↗

Circadian Gene CLOCK Affects Drug-Resistant Gene Expression and Cell Proliferation in Ovarian Cancer SKOV3/DDP Cell Lines Through AutophagySemantic proximity Read ↗

Melatonin Sensitize the Ovarian Cancer Cells to Cisplatin through suppression of PI3K/Akt pathwaySemantic proximity Read ↗

MiR-770-5p inhibits cisplatin chemoresistance in human ovarian cancer by targeting ERCC2Semantic proximity Read ↗

The contribution of copper efflux transporters ATP7A and ATP7B to chemoresistance and personalized medicine in ovarian cancerSemantic proximity Read ↗

Long Noncoding RNA TUG1 Promotes Autophagy-Associated Paclitaxel Resistance by Sponging miR-29b-3p in Ovarian Cancer CellsSemantic proximity Read ↗

Cisplatin in Ovarian Cancer Treatment—Known Limitations in Therapy Force New SolutionsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.